Life Sciences News in Poland – September 2025

September brought several legislative developments in the healthcare sector in Poland, including in particular:

• Medicinal products: Amendment to the reimbursement act now in force
• Healthcare: Entry into force of amendments to the Act on Healthcare Services Financed from Public Funds and the Act on Medical Activity
• Medical devices: Borderline products – update of MDCG guidance
• Food: Entry into force of amendments to the regulation on the composition and labelling of dietary supplements.

We encourage you to read Life Sciences – September 2025 Regulatory Update, prepared by the DLA Piper Poland Life Sciences team: Dr Andrzej Balicki, Jolanta Dąbrowicz and Urszula Grębowska.